PFE vs SAM · P/E 20, rev $62.58B vs rev $2.01B
Pfizer Inc (PFE) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. SAM currently screens at market cap $1.79B.
Not investment advice. Open the PFE and SAM stock pages for the full models.
Not investment advice.